Aptiom (eslicarbazepine acetate)

pCPA File Number: 20853
Negotiation Status:
Concluded with an LOI
Indication(s):
Epilepsy, partial-onset seizures
Sponsor/Manufacturer:
Sunovion Pharmaceuticals Canada Inc.
CADTH Project Number:
SR0391
pCPA Engagement Letter Issued:
Negotiation Process Concluded: